Abstract

Microalgae have been considered as a renewable source of nutritional, cosmetic and pharmaceutical compounds. The ability to produce health-beneficial long-chain polyunsaturated fatty acids (LC-PUFA) is of high interest. LC-PUFA and their metabolic lipid mediators, modulate key inflammatory pathways in numerous models. In particular, the metabolism of arachidonic acid under inflammatory challenge influences the immune reactivity of macrophages. However, less is known about another omega-6 LC-PUFA, dihomo-γ-linolenic acid (DGLA), which exhibits potent anti-inflammatory activities, which contrast with its delta-5 desaturase product, arachidonic acid (ARA). In this work, we examined whether administrating DGLA would modulate the inflammatory response in the RAW264.7 murine macrophage cell line. DGLA was applied for 24 h in the forms of carboxylic (free) acid, ethyl ester, and ethyl esters obtained from the DGLA-accumulating delta-5 desaturase mutant strain P127 of the green microalga Lobosphaera incisa. DGLA induced a dose-dependent increase in the RAW264.7 cells’ basal secretion of the prostaglandin PGE1. Upon bacterial lipopolysaccharide (LPS) stimuli, the enhanced production of pro-inflammatory cytokines, tumor necrosis factor alpha (TNFα) and interleukin 1β (IL-1β), was affected little by DGLA, while interleukin 6 (IL-6), nitric oxide, and total reactive oxygen species (ROS) decreased significantly. DGLA administered at 100 µM in all forms attenuated the LPS-induced expression of the key inflammatory genes in a concerted manner, in particular iNOS, IL-6, and LxR, in the form of free acid. PGE1 was the major prostaglandin detected in DGLA-supplemented culture supernatants, whose production prevailed over ARA-derived PGE2 and PGD2, which were less affected by LPS-stimulation compared with the vehicle control. An overall pattern of change indicated DGLA’s induced alleviation of the inflammatory state. Finally, our results indicate that microalgae-derived, DGLA-enriched ethyl esters (30%) exhibited similar activities to DGLA ethyl esters, strengthening the potential of this microalga as a potent source of this rare anti-inflammatory fatty acid.

Highlights

  • Long-chain polyunsaturated fatty acids (LC-PUFA) are key precursors of a broad array of lipid mediators of health and disease

  • The health-beneficial properties of DGLA are related to its crosstalk with arachidonic acid (ARA) metabolism and the production of a distinct group of eicosanoids and other lipid mediators that contribute to the resolution of inflammation and influence survival of cancer cells [6]

  • We showed that endogenous DGLA might change the basal secretion levels of the prostaglandins prostaglandin E1 (PGE1) and PGE2

Read more

Summary

Introduction

Long-chain polyunsaturated fatty acids (LC-PUFA) are key precursors of a broad array of lipid mediators of health and disease. LC-PUFA of the omega-3 family (e.g., eicosapentanoic acid, EPA, 20:5 n-3, docosahexaenoic acid, 22:6 n-3) and the omega-6 family (e.g., arachidonic acid, ARA, 20:4 n-6) have attracted considerable attention because of their numerous biomedical activities, and the important roles they play in human health and nutrition [1]. The immediate precursor of ARA, dihomo-γ-linolenic acid (DGLA), is a 20-carbon omega-6 LC-PUFA (20:3 n-6), derived in vivo from the essential omega-6 linoleic acid (18:2 n-6). The health-beneficial properties of DGLA are related to its crosstalk with ARA metabolism and the production of a distinct group of eicosanoids and other lipid mediators that contribute to the resolution of inflammation and influence survival of cancer cells [6]. The natural sources of DGLA are very limited as it occurs as an intermediate in ARA biosynthesis and does not accumulate in considerable amounts [7]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call